Understanding the molecular mechanisms driving metastasis.

about

Hallmarks of Bone Metastasis.LTBP3 promotes early metastatic events during cancer cell dissemination.Murine breast cancer mastectomy model that predicts patient outcomes for drug development.Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response

P2860

Q48303279-83264627-94AF-450B-B2B2-9281DA209195 Q49952435-5A3A1011-EC8F-4745-AFE3-56371DB653D8 Q50099125-F6F738EC-527E-4299-8989-32CE6EC01777 Q59133970-90EEB5D7-D584-44EB-BAF0-BE41B4CB46A3

P2860

Understanding the molecular mechanisms driving metastasis.

Item

http://www.wikidata.org/entity/Q42353406

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Understanding the molecular mechanisms driving metastasis.

@en

Understanding the molecular mechanisms driving metastasis.

@nl

type

Item

label

Understanding the molecular mechanisms driving metastasis.

@en

Understanding the molecular mechanisms driving metastasis.

@nl

prefLabel

Understanding the molecular mechanisms driving metastasis.

@en

Understanding the molecular mechanisms driving metastasis.

@nl

P1476

Understanding the molecular mechanisms driving metastasis.

@en

P2860

Genes that mediate breast cancer metastasis to the brain

Metastasis: from dissemination to organ-specific colonization

Cancer metastasis: building a framework

VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.

Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis.

ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.

Surviving at a distance: organ specific metastasis.

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay.

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events.

P304

3-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1002/1878-0261.12024

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eduard Batlle

Roger Gomis

Joan Massagué Solé

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28085221

http://www.w3.org/2001/XMLSchema#string

P932

5423223

http://www.w3.org/2001/XMLSchema#string

Understanding the molecular mechanisms driving metastasis.

about

P2860

P2860

Understanding the molecular mechanisms driving metastasis.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932